The Drug Discovery Outsourcing Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Faced with declining innovation and increasing financial pressure to reduce R&D expenditures across the board, pharmaceutical companies have realised that the top-down, blockbuster model of drug discovery is no longer viable. Therefore, there is currently a trend in the pharma market of shifting towards a more distributive model for R&D. In order to ensure future revenue growth, the pharmaceutical industry needs to refocus their investment on early drug discovery.
Public-private partnerships where companies form alliances with academic research laboratories have been suggested as the way forward. The advantage of this approach is that the results of drug discovery research would be made publicly available for everyone to see. The advantage of this approach is that the results of drug discovery research would be publicly available for everyone to see. This would leverage the expertise of global academia with the potential to arrive at therapies more quickly.
What Questions Should You Ask before Buying a Market Research Report?
• How is the drug discovery outsourcing market evolving?
• What is driving and restraining the drug discovery outsourcing market?
• How will each drug discovery outsourcing submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each drug discovery outsourcing submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading drug discovery outsourcing markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• What are the drug discovery outsourcing projects for these leading companies?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of
drug discovery outsourcing projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the drug discovery outsourcing market?
• Where is the drug discovery outsourcing market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the drug discovery outsourcing market today, and over the next 10 years:
• Our 389-page report provides 134 tables and 186 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the drug discovery outsourcing market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, and restraints), Porter’s Five Forces Analysis, and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Service Type
• Chemistry Services
• Biology Services
Workflow
• Target Identification & Screening
• Target Validation & Functional Informatics
• Lead Identification & Candidate Optimization
• Preclinical Development
• Other Associated Workflow
Therapeutic Area
• Oncology
• Infectious Disease
• Central Nervous System
• Immunology
• Cardiovascular Disease
• Metabolic Disease
• Respiratory Disease
• Others
Molecule Type
• Large Molecules
• Small Molecules
End-users
• Pharmaceutical & Biotechnology Companies
• Academic Institutes
• Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 24 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• South-East Asia
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of Latin America
MEA
• GCC
• South Africa
• Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Drug Discovery Outsourcing Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• Aragen Life Sciences Pvt. Ltd. (GVK Biosciences)
• Charles River Laboratories
• Curia Global, Inc.
• Dalton Pharma
• Domainex
• Eurofins
• Evotec AG
• Genscript
• Jubilant Biosys Ltd.
• Laboratory Corporation of America Holdings
• Pharmaron
• QIAGEN N.V.
• Selvita
• Sundia Meditech Co Ltd.
• Sygnature Discovery
• Syngene International
• Thermo Fisher Scientific Inc.
• WuXi AppTec
Overall world revenue for Drug Discovery Outsourcing Market, 2023 to 2033 in terms of value the market will surpass US$10,644.0 million in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Drug Discovery Outsourcing Market, 2023 to 2033 report help you?
In summary, our 380+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for Drug Discovery Outsourcing Market, 2023 to 2033 Market, with forecasts for service type, workflow, therapeutic area, molecule type, and end-users, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for five regional and 24 key national markets – See forecasts for the Drug Discovery Outsourcing Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 18 of the major companies involved in the Drug Discovery Outsourcing Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Drug Discovery Outsourcing Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Drug Discovery Outsourcing Market Report 2023-2033: Forecasts by Service Type (Chemistry Services, Biology Services), by Workflow (Target Identification & Screening, Target Validation & Functional Informatics, Lead Identification & Candidate Optimisation, Preclinical Development, Other Associated Workflow), by Therapeutic Area (Oncology, Infectious Disease, Central Nervous System, Immunology, Cardiovascular Disease, Metabolic Disease, Respiratory Disease, Others), by Molecule Type (Large Molecules, Small Molecules), by End-users (Pharmaceutical & Biotechnology Companies, Academic Institutes, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Drug Discovery Outsourcing Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Reduced Pharmaceutical and Biotech R&D Budgets
3.2.1.2 Emerging Markets are a Popular Destination for CROs
3.2.1.3 Improving Conditions in the Industry will Drive Healthy Growth
3.2.1.4 Cost Reduction: A Central Driver for Outsourcing
3.2.1.5 Accelerating the Discovery of Drug Candidates
3.2.2 Market Restraining Factors
3.2.2.1 Limited IP Protection
3.2.2.2 Threat of Private Public Alliances
3.2.3 Market Opportunities
3.2.3.1 Strategic Partnerships to Offer Lucrative Growth Prospects
3.2.3.2 Investment in Artificial Intelligence to Offer Fresh Revenue Pockets
3.2.3.3 Available Scope for the Expansion of CROs
3.2.3.4 Targeted Therapies: Advances in Biologics and Orphan Drugs
3.3 COVID-19 Impact Analysis
3.4 R&D Outsourcing Business Model (Fee-for-Service)
3.5 Collaborations Between CRO and Pharmaceutical Industry
3.6 Porter’s Five Forces Analysis
3.6.1 Competitive Rivalry: High
3.6.2 Threat of Substitutes: Medium
3.6.3 Bargaining Power of Buyer: High
3.6.4 Bargaining Power of Suppliers: Medium
3.6.5 Threat of New Entrants: Medium
4 Drug Discovery Outsourcing Market Analysis by Service Type
4.1 Key Findings
4.2 Service Type Segment: Market Attractiveness Index
4.3 Drug Discovery Outsourcing Market Size Estimation and Forecast by Service Type
4.4 Chemistry Services
4.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.5 Biology Services
4.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
4.5.2 Market Share by Region, 2023 & 2033 (%)
5 Drug Discovery Outsourcing Market Analysis by Workflow
5.1 Key Findings
5.2 Workflow Segment: Market Attractiveness Index
5.3 Drug Discovery Outsourcing Market Size Estimation and Forecast by Workflow
5.4 Target Identification & Screening
5.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Target Validation & Functional Informatics
5.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Lead Identification & Candidate Optimization
5.6.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Preclinical Development
5.7.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 Other Associated Workflow
5.8.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
5.8.2 Market Share by Region, 2023 & 2033 (%)
6 Drug Discovery Outsourcing Market Analysis by Therapeutic Area
6.1 Key Findings
6.2 Therapeutic Area Segment: Market Attractiveness Index
6.3 Drug Discovery Outsourcing Market Size Estimation and Forecast by Therapeutic Area
6.4 Oncology
6.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Infectious Disease
6.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Central Nervous System
6.6.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 Immunology
6.7.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.7.2 Market Share by Region, 2023 & 2033 (%)
6.8 Cardiovascular Disease
6.8.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.8.2 Market Share by Region, 2023 & 2033 (%)
6.9 Metabolic Disease
6.9.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.9.2 Market Share by Region, 2023 & 2033 (%)
6.10 Respiratory Disease
6.10.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.10.2 Market Share by Region, 2023 & 2033 (%)
6.11 Others
6.11.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
6.11.2 Market Share by Region, 2023 & 2033 (%)
7 Drug Discovery Outsourcing Market Analysis by Molecule Type
7.1 Key Findings
7.2 Molecule Type Segment: Market Attractiveness Index
7.3 Drug Discovery Outsourcing Market Size Estimation and Forecast by Molecule Type
7.4 Large Molecules
7.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Small Molecules
7.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
7.5.2 Market Share by Region, 2023 & 2033 (%)
8 Drug Discovery Outsourcing Market Analysis by End-users
8.1 Key Findings
8.2 End-users Segment: Market Attractiveness Index
8.3 Drug Discovery Outsourcing Market Size Estimation and Forecast by End-users
8.4 Pharmaceutical & Biotechnology Companies
8.4.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
8.4.2 Market Share by Region, 2023 & 2033 (%)
8.5 Academic Institutes
8.5.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
8.5.2 Market Share by Region, 2023 & 2033 (%)
8.6 Others
8.6.1 Market Forecast by Region, 2023-2033 (US$ Mn, AGR %)
8.6.2 Market Share by Region, 2023 & 2033 (%)
9 Drug Discovery Outsourcing Market Analysis by Region
9.1 Key Findings
9.2 Regional Market Size Estimation and Forecast
10 North America Drug Discovery Outsourcing Market Analysis
10.1 Key Findings
10.2 North America Drug Discovery Outsourcing Market Attractiveness Index
10.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
10.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
10.5 Market Size Estimation and Forecast by Service Type, 2023-2033 (US$ Mn)
10.6 Market Size Estimation and Forecast by Workflow, 2023-2033 (US$ Mn)
10.7 Market Size Estimation and Forecast by Therapeutic Area, 2023-2033 (US$ Mn)
10.8 Market Size Estimation and Forecast by Molecule Type, 2023-2033 (US$ Mn)
10.9 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
10.10 U.S. Drug Discovery Outsourcing Market Analysis
10.11 Canada Drug Discovery Outsourcing Market Analysis
11 Europe Drug Discovery Outsourcing Market Analysis
11.1 Key Findings
11.2 Europe Drug Discovery Outsourcing Market Attractiveness Index
11.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
11.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
11.5 Market Size Estimation and Forecast by Service Type, 2023-2033 (US$ Mn)
11.6 Market Size Estimation and Forecast by Workflow, 2023-2033 (US$ Mn)
11.7 Market Size Estimation and Forecast by Therapeutic Area, 2023-2033 (US$ Mn)
11.8 Market Size Estimation and Forecast by Molecule Type, 2023-2033 (US$ Mn)
11.9 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
11.10 Germany Drug Discovery Outsourcing Market Analysis
11.11 UK Drug Discovery Outsourcing Market Analysis
11.12 France Drug Discovery Outsourcing Market Analysis
11.13 Italy Drug Discovery Outsourcing Market Analysis
11.14 Spain Drug Discovery Outsourcing Market Analysis
11.15 Russia Drug Discovery Outsourcing Market Analysis
11.16 Rest of Europe Drug Discovery Outsourcing Market Analysis
12 Asia Pacific Drug Discovery Outsourcing Market Analysis
12.1 Key Findings
12.2 Asia Pacific Drug Discovery Outsourcing Market Attractiveness Index
12.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
12.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
12.5 Market Size Estimation and Forecast by Service Type, 2023-2033 (US$ Mn)
12.6 Market Size Estimation and Forecast by Workflow, 2023-2033 (US$ Mn)
12.7 Market Size Estimation and Forecast by Therapeutic Area, 2023-2033 (US$ Mn)
12.8 Market Size Estimation and Forecast by Molecule Type, 2023-2033 (US$ Mn)
12.9 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
12.10 Japan Drug Discovery Outsourcing Market Analysis
12.11 China Drug Discovery Outsourcing Market Analysis
12.12 India Drug Discovery Outsourcing Market Analysis
12.13 Australia Drug Discovery Outsourcing Market Analysis
12.14 South Korea Drug Discovery Outsourcing Market Analysis
12.15 South-East Asia Drug Discovery Outsourcing Market Analysis
12.16 Rest of Asia Pacific Drug Discovery Outsourcing Market Analysis
13 Latin America Drug Discovery Outsourcing Market Analysis
13.1 Key Findings
13.2 Latin America Drug Discovery Outsourcing Market Attractiveness Index
13.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
13.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
13.5 Market Size Estimation and Forecast by Service Type, 2023-2033 (US$ Mn)
13.6 Market Size Estimation and Forecast by Workflow, 2023-2033 (US$ Mn)
13.7 Market Size Estimation and Forecast by Therapeutic Area, 2023-2033 (US$ Mn)
13.8 Market Size Estimation and Forecast by Molecule Type, 2023-2033 (US$ Mn)
13.9 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
13.10 Brazil Drug Discovery Outsourcing Market Analysis
13.11 Mexico Drug Discovery Outsourcing Market Analysis
13.12 Argentina Drug Discovery Outsourcing Market Analysis
13.13 Colombia Drug Discovery Outsourcing Market Analysis
13.14 Rest of Latin America Drug Discovery Outsourcing Market Analysis
14 MEA Drug Discovery Outsourcing Market Analysis
14.1 Key Findings
14.2 MEA Drug Discovery Outsourcing Market Attractiveness Index
14.3 Market Size by Country, 2023, 2028 & 2033 (US$ Mn)
14.4 Market Size Estimation and Forecast by Country, 2023-2033 (US$ Mn)
14.5 Market Size Estimation and Forecast by Service Type, 2023-2033 (US$ Mn)
14.6 Market Size Estimation and Forecast by Workflow, 2023-2033 (US$ Mn)
14.7 Market Size Estimation and Forecast by Therapeutic Area, 2023-2033 (US$ Mn)
14.8 Market Size Estimation and Forecast by Molecule Type, 2023-2033 (US$ Mn)
14.9 Market Size Estimation and Forecast by End-users, 2023-2033 (US$ Mn)
14.10 GCC Drug Discovery Outsourcing Market Analysis
14.11 South Africa Drug Discovery Outsourcing Market Analysis
14.12 Rest of MEA Drug Discovery Outsourcing Market Analysis
15 Company Profiles
15.1 Curia Global, Inc.
15.1.1 Company Snapshot
15.1.2 Company Overview
15.1.3 Product Benchmarking
15.1.4 Strategic Outlook
15.2 Charles River Laboratories
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Financial Analysis
15.2.3.1 Net Revenue, 2015-2022
15.2.3.2 Regional Market Share, 2022
15.2.4 Product Benchmarking
15.2.5 Strategic Outlook
15.3 Dalton Pharma
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Product Benchmarking
15.3.4 Strategic Outlook
15.4 Domainex
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Product Benchmarking
15.4.4 Strategic Outlook
15.5 Eurofins
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Financial Analysis
15.5.3.1 Net Revenue, 2016-2022
15.5.3.2 Regional Market Share, 2022
15.5.4 Product Benchmarking
15.5.5 Strategic Outlook
15.6 Evotec AG
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.3.1 Net Revenue, 2015-2022
15.6.3.2 Regional Market Share, 2022
15.6.3.3 R&D, 2015-2022
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.7 Genscript
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Financial Analysis
15.7.3.1 Net Revenue, 2015-2022
15.7.4 Product Benchmarking
15.7.5 Strategic Outlook
15.8 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences)
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Product Benchmarking
15.8.4 Strategic Outlook
15.9 Jubilant Biosys Ltd.
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Financial Analysis
15.9.3.1 Net Revenue, 2015-2020
15.9.4 Product Benchmarking
15.9.5 Strategic Outlook
15.10 Laboratory Corporation of America Holdings
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.3.1 Net Revenue, 2015-2022
15.10.3.2 Regional Market Share, 2022
15.10.4 Product Benchmarking
15.10.5 Strategic Outlook
15.11 Pharmaron
15.11.1 Company Snapshot
15.11.2 Company Overview
15.11.3 Financial Analysis
15.11.3.1 Net Revenue, 2016-2022
15.11.4 Product Benchmarking
15.11.5 Strategic Outlook
15.12 QIAGEN N.V.
15.12.1 Company Snapshot
15.12.2 Company Overview
15.12.3 Financial Analysis
15.12.3.1 Net Revenue, 2015-2022
15.12.3.2 R&D, 2015-2022
15.12.4 Product Benchmarking
15.12.5 Strategic Outlook
15.13 Selvita
15.13.1 Company Snapshot
15.13.2 Company Overview
15.13.3 Product Benchmarking
15.13.4 Strategic Outlook
15.14 Sundia Meditech Co Ltd.
15.14.1 Company Snapshot
15.14.2 Company Overview
15.14.3 Product Benchmarking
15.15 Sygnature Discovery
15.15.1 Company Snapshot
15.15.2 Company Overview
15.15.3 Product Benchmarking
15.15.4 Strategic Outlook
15.16 Syngene International
15.16.1 Company Snapshot
15.16.2 Company Overview
15.16.3 Financial Analysis
15.16.3.1 Net Revenue, 2015-2022
15.16.3.2 Regional Market Share, 2022
15.16.4 Product Benchmarking
15.16.5 Strategic Outlook
15.17 Thermo Fisher Scientific Inc.
15.17.1 Company Snapshot
15.17.2 Company Overview
15.17.3 Financial Analysis
15.17.3.1 Net Revenue, 2015-2022
15.17.3.2 Regional Market Share, 2022
15.17.3.3 R&D, 2015-2022
15.17.4 Product Benchmarking
15.17.5 Strategic Outlook
15.18 WuXi AppTec
15.18.1 Company Snapshot
15.18.2 Company Overview
15.18.3 Financial Analysis
15.18.3.1 Net Revenue, 2015-2021
15.18.3.2 Regional Market Share, 2021
15.18.4 Product Benchmarking
15.18.5 Strategic Outlook
16 Conclusion and Recommendations
16.1 Concluding Remarks from Visiongain
16.2 Recommendations for Market Players
List of Tables
Table 1 Drug Discovery Outsourcing Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 2 Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 3 Chemistry Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 4 Biology Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 5 Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 6 Target Identification & Screening Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 7 Target Validation & Functional Informatics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Lead Identification & Candidate Optimization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 9 Preclinical Development Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Other Associated Workflow Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 11 Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 12 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 13 Infectious Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Central Nervous System Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 15 Immunology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Cardiovascular Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 17 Metabolic Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 18 Respiratory Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 20 Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 Large Molecules Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Small Molecules Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 25 Academic Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 26 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 27 Drug Discovery Outsourcing Market Forecast by Region 2023-2033 (US$ Million, AGR%, CAGR%)
Table 28 North America Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 29 North America Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 30 North America Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 31 North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 32 North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 33 North America Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 U.S. Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 35 Canada Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 Europe Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 38 Europe Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 39 Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 41 Europe Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 42 Germany Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 43 UK Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 France Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 Italy Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Spain Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Russia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Rest of Europe Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Asia Pacific Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Asia Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Asia Pacific Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Asia Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 53 Asia Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Asia Pacific Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 55 Japan Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 China Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 India Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Australia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 South Korea Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 South-East Asia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Rest of Asia Pacific Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Latin America Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 64 Latin America Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 65 Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 Latin America Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 Brazil Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 Mexico Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 Argentina Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 Colombia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 72 Rest of Latin America Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 73 MEA Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 MEA Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 MEA Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 76 MEA Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 77 MEA Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 78 MEA Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 79 GCC Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 80 South Africa Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 81 Rest of MEA Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 82 Curia Global, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 83 Curia Global, Inc.: Product Benchmarking
Table 84 Curia Global, Inc.: Strategic Outlook
Table 85 Charles River Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 86 Charles River Laboratories: Product Benchmarking
Table 87 Charles River Laboratories: Strategic Outlook
Table 88 Dalton Pharma: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 89 Dalton Pharma: Product Benchmarking
Table 90 Dalton Pharma: Strategic Outlook
Table 91 Domainex: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 92 Domainex: Product Benchmarking
Table 93 Domainex: Strategic Outlook
Table 94 Eurofins: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 95 Eurofins: Product Benchmarking
Table 96 Eurofins: Strategic Outlook
Table 97 Evotec AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 98 Evotec AG: Product Benchmarking
Table 99 Evotec AG: Strategic Outlook
Table 100 Genscript: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 101 Genscript: Product Benchmarking
Table 102 Genscript: Strategic Outlook
Table 103 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences): Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 104 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences): Product Benchmarking
Table 105 Aragen Life Sciences Pvt. Ltd. (GVK Biosciences): Strategic Outlook
Table 106 Jubilant Biosys Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Jubilant Biosys Ltd.: Product Benchmarking
Table 108 Jubilant Biosys Ltd.: Strategic Outlook
Table 109 Laboratory Corporation of America Holdings: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Laboratory Corporation of America Holdings: Product Benchmarking
Table 111 Laboratory Corporation of America Holdings: Strategic Outlook
Table 112 Pharmaron: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 113 Pharmaron: Product Benchmarking
Table 114 Pharmaron: Strategic Outlook
Table 115 QIAGEN N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 116 QIAGEN N.V.: Product Benchmarking
Table 117 QIAGEN N.V.: Strategic Outlook
Table 118 Selvita: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 119 Selvita: Product Benchmarking
Table 120 Selvita: Strategic Outlook
Table 121 Sundia Meditech Co Ltd.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 122 Sundia Meditech Co Ltd.: Product Benchmarking
Table 123 Sygnature Discovery: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 124 Sygnature Discovery: Product Benchmarking
Table 125 Sygnature Discovery: Strategic Outlook
Table 126 Syngene International: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 127 Syngene International: Product Benchmarking
Table 128 Syngene International: Strategic Outlook
Table 129 Thermo Fisher Scientific Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 Thermo Fisher Scientific Inc.: Product Benchmarking
Table 131 Thermo Fisher Scientific Inc.: Strategic Outlook
Table 132 WuXi AppTec: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 WuXi AppTec: Product Benchmarking
Table 134 WuXi AppTec.: Strategic Outlook
List of Figures
Figure 1 Drug Discovery Outsourcing Market Segmentation
Figure 2 Drug Discovery Outsourcing Market by Service Type: Market Attractiveness Index
Figure 3 Drug Discovery Outsourcing Market by Workflow: Market Attractiveness Index
Figure 4 Drug Discovery Outsourcing Market by Therapeutic Area: Market Attractiveness Index
Figure 5 Drug Discovery Outsourcing Market by Molecule Type: Market Attractiveness Index
Figure 6 Drug Discovery Outsourcing Market by End-users: Market Attractiveness Index
Figure 7 Drug Discovery Outsourcing Market Attractiveness Index by Region
Figure 8 Drug Discovery Outsourcing Market: Market Dynamics
Figure 9 Drug Discovery Outsourcing Market by Region, 2023-2033 (US$ Mn, AGR %): “V” Shaped Recovery
Figure 10 Drug Discovery Outsourcing Market by Region, 2023-2033 (US$ Mn, AGR %): “U” Shaped Recovery
Figure 11 Drug Discovery Outsourcing Market by Region, 2023-2033 (US$ Mn, AGR %): “W” Shaped Recovery
Figure 12 Drug Discovery Outsourcing Market by Region, 2023-2033 (US$ Mn, AGR %): “L” Shaped Recovery
Figure 13 Drug Discovery Outsourcing Market: Porter’s Five Forces Analysis
Figure 14 Drug Discovery Outsourcing Market Attractiveness Index by Service Type
Figure 15 Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 16 Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023, 2028, 2033 (%)
Figure 17 Chemistry Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 18 Chemistry Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Biology Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 20 Biology Services Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 21 Drug Discovery Outsourcing Market Attractiveness Index by Service Type
Figure 22 Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 23 Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023, 2028, 2033 (%)
Figure 24 Target Identification & Screening Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 25 Target Identification & Screening Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 26 Target Validation & Functional Informatics Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 27 Target Validation & Functional Informatics Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Lead Identification & Candidate Optimization Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 29 Lead Identification & Candidate Optimization Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Preclinical Development Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 31 Preclinical Development Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Other Associated Workflow Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 33 Other Associated Workflow Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 Drug Discovery Outsourcing Market Attractiveness Index by Therapeutic Area
Figure 35 Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 36 Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023, 2028, 2033 (%)
Figure 37 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 38 Oncology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 39 Infectious Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 40 Infectious Disease Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 41 Central Nervous System Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 42 Central Nervous System Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Immunology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 44 Immunology Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Cardiovascular Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 46 Cardiovascular Disease Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 Metabolic Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 48 Metabolic Disease Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Respiratory Disease Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 50 Respiratory Disease Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 51 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 52 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 53 Drug Discovery Outsourcing Market Attractiveness Index by Molecule Type
Figure 54 Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 55 Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023, 2028, 2033 (%)
Figure 56 Large Molecules Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 57 Large Molecules Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 58 Small Molecules Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 59 Small Molecules Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 60 Drug Discovery Outsourcing Market Attractiveness Index by End-users
Figure 61 Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 62 Drug Discovery Outsourcing Market Share Forecast by End-users, 2023, 2028, 2033 (%)
Figure 63 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 64 Pharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 65 Academic Institutes Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 66 Academic Institutes Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 67 Others Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR %)
Figure 68 Others Segment Market Share Forecast by Region, 2023 & 2033 (%)
Figure 69 Drug Discovery Outsourcing Market Forecast by Region 2023, 2028, 2033 (Revenue, CAGR%)
Figure 70 Drug Discovery Outsourcing Market Share Forecast by Region 2023, 2028, 2033 (%)
Figure 71 Drug Discovery Outsourcing Market by Region, 2023-2033 (US$ Mn)
Figure 72 North America Drug Discovery Outsourcing Market Attractiveness Index
Figure 73 North America Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 74 North America Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ million)
Figure 75 North America Drug Discovery Outsourcing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 76 North America Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 77 North America Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023 & 2033 (%)
Figure 78 North America Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 79 North America Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023 & 2033 (%)
Figure 80 North America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 81 North America Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 82 North America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 83 North America Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023 & 2033 (%)
Figure 84 North America Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 85 North America Drug Discovery Outsourcing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 86 U.S. Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 87 Canada Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 88 Europe Drug Discovery Outsourcing Market Attractiveness Index
Figure 89 Europe Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 90 Europe Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ million)
Figure 91 Europe Drug Discovery Outsourcing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 92 Europe Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 93 Europe Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023 & 2033 (%)
Figure 94 Europe Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 95 Europe Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023 & 2033 (%)
Figure 96 Europe Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 97 Europe Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 98 Europe Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 99 Europe Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023 & 2033 (%)
Figure 100 Europe Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 101 Europe Drug Discovery Outsourcing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 102 Germany Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 103 UK Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 104 France Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 105 Italy Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 106 Spain Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 107 Russia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 108 Rest of Europe Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 109 Asia Pacific Drug Discovery Outsourcing Market Attractiveness Index
Figure 110 Asia Pacific Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ million)
Figure 111 Asia Pacific Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million)
Figure 112 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 113 Asia Pacific Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 114 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023 & 2033 (%)
Figure 115 Asia Pacific Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 116 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023 & 2033 (%)
Figure 117 Asia Pacific Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 118 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 119 Asia Pacific Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 120 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023 & 2033 (%)
Figure 121 Asia Pacific Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 122 Asia Pacific Drug Discovery Outsourcing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 123 Japan Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 124 China Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 125 India Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 126 Australia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 127 South Korea Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 128 South-East Asia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 129 Rest of Asia Pacific Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 130 Latin America Drug Discovery Outsourcing Market Attractiveness Index
Figure 131 Latin America Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ Million)
Figure 132 Latin America Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million)
Figure 133 Latin America Drug Discovery Outsourcing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 134 Latin America Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 135 Latin America Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023 & 2033 (%)
Figure 136 Latin America Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 137 Latin America Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023 & 2033 (%)
Figure 138 Latin America Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 139 Latin America Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 140 Latin America Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 141 Latin America Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023 & 2033 (%)
Figure 142 Latin America Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 143 Latin America Drug Discovery Outsourcing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 144 Brazil Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 145 Mexico Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 146 Argentina Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 147 Colombia Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 148 Rest of Latin America Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 149 MEA Drug Discovery Outsourcing Market Attractiveness Index
Figure 150 MEA Drug Discovery Outsourcing Market by Country, 2023, 2028 & 2033 (US$ Million)
Figure 151 MEA Drug Discovery Outsourcing Market Forecast by Country, 2023-2033 (US$ Million)
Figure 152 MEA Drug Discovery Outsourcing Market Share Forecast by Country, 2023 & 2033 (%)
Figure 153 MEA Drug Discovery Outsourcing Market Forecast by Service Type, 2023-2033 (US$ Million, AGR %)
Figure 154 MEA Drug Discovery Outsourcing Market Share Forecast by Service Type, 2023 & 2033 (%)
Figure 155 MEA Drug Discovery Outsourcing Market Forecast by Workflow, 2023-2033 (US$ Million, AGR %)
Figure 156 MEA Drug Discovery Outsourcing Market Share Forecast by Workflow, 2023 & 2033 (%)
Figure 157 MEA Drug Discovery Outsourcing Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR %)
Figure 158 MEA Drug Discovery Outsourcing Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 159 MEA Drug Discovery Outsourcing Market Forecast by Molecule Type, 2023-2033 (US$ Million, AGR %)
Figure 160 MEA Drug Discovery Outsourcing Market Share Forecast by Molecule Type, 2023 & 2033 (%)
Figure 161 MEA Drug Discovery Outsourcing Market Forecast by End-users, 2023-2033 (US$ Million, AGR %)
Figure 162 MEA Drug Discovery Outsourcing Market Share Forecast by End-users, 2023 & 2033 (%)
Figure 163 GCC Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 164 South Africa Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 165 Rest of MEA Drug Discovery Outsourcing Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 166 Charles River Laboratories: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 167 Charles River Laboratories: Regional Market Share, 2022 (%)
Figure 168 Eurofins: Net Revenue, 2016-2022 (US$ million, AGR%)
Figure 169 Eurofins: Regional Market Share, 2022 (%)
Figure 170 Evotec AG: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 171 Evotec AG: Regional Market Share, 2022 (%)
Figure 172 Evotec AG: R&D, 2015-2022 (US$ million, AGR%)
Figure 173 Genscript: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 174 Jubilant Biosys Ltd.: Net Revenue, 2015-2020 (US$ million, AGR%)
Figure 175 Laboratory Corporation of America Holdings: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 176 Laboratory Corporation of America Holdings: Regional Market Share, 2022 (%)
Figure 177 Pharmaron: Net Revenue, 2016-2022 (US$ million, AGR%)
Figure 178 QIAGEN N.V.: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 179 QIAGEN N.V.: R&D, 2015-2022 (US$ million, AGR%)
Figure 180 Syngene International: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 181 Syngene International: Regional Market Share, 2022 (%)
Figure 182 Thermo Fisher Scientific Inc.: Net Revenue, 2015-2022 (US$ million, AGR%)
Figure 183 Thermo Fisher Scientific Inc.: Regional Market Share, 2022 (%)
Figure 184 Thermo Fisher Scientific Inc.: R&D, 2015-2022 (US$ million, AGR%)
Figure 185 WuXi AppTec: Net Revenue, 2015-2021 (US$ million, AGR%)
Figure 186 WuXi AppTec: Regional Market Share, 2021 (%)
List of Companies Profiled in the Report
Aragen Life Sciences Pvt. Ltd. (GVK Biosciences)
Charles River Laboratories
Curia Global, Inc.
Dalton Pharma
Domainex
Eurofins
Evotec AG
Genscript
Jubilant Biosys Ltd.
Laboratory Corporation of America Holdings
Pharmaron
QIAGEN N.V.
Selvita
Sundia Meditech Co Ltd.
Sygnature Discovery
Syngene International
Thermo Fisher Scientific Inc.
WuXi AppTec
List of Other Companies Mentioned in the Report
Absorption Systems
Allergan Biologics Limited
Amphista Therapeutics Ltd .
Amphista Therapeutics Ltd.
Arsenal Biosciences, Inc.
ASC Therapeutics
ATEM Structural Discovery (ATEM)
Avectas
Beijing Apollo Venus Biomedical Technology Limited
Berkeley Lights, Inc.
BLIRT S.A.
Blueprint Medicines Corporation
Bristol Myers Squibb
Celltrio
Chinook Therapeutics, Inc.
Cognate BioServices
ConcertAI, LLC
Cypre, Inc.
Cyprotex
Daewoong Pharma
Discovery Life Sciences
Eli Lilly and Company
Epigeneron Inc.
Explora BioLabs Holdings, Inc.
Fidelta
Galapagos NV
GlaxoSmithKline (GSK)
GVK BIO
HealthVerity, Inc.
IAMA Therapeutics
Iktos
IMIDomics, Inc.
Integrity Bio
Johnson & Johnson
Kazia
KWS BioTest
LakePharma
Legend Biotech Corporation
Merck
Myriad Genetics'
Nanoscope Therapeutics, Inc.
NeoVac
NovAliX
Novartis
Novo Nordisk
Ovia Health
OXGENE
OxVax
Peak Proteins Ltd.
PeproTech, Inc.
Pfizer
Pharmaron Beijing Co., Limited
Pharos Therapeutics
Prisma Health
Purespring Therapeutics
ReachBio Research Labs
Related Sciences
Retrogenix Limited
Rigenerand Srl
Roche
Rznomics Inc.
SAMDI Tech, Inc.
Sandoz AG
SB Drug Discovery
SB Drug Discovery
Secarna Pharmaceuticals GmbH & Co. KG
Sernova Corp
Sintalica Bioscience Corp.
Skyhawk Therapeutics
Stirling Square Capital Partners
Sysmex Corporation
Taros Chemicals
Toxikon Corporation
Tubulis GmbH
Valo Health, Inc.
Vigene Biosciences, Inc.
Xcell Biosciences, Inc.
Ziphius Vaccines
List of Associations Mentioned in the Report
Bill & Melinda Gates Foundation
Biomedical Advanced Research and Development Authority (BARDA)
Bioprocessing Technology Institute (BTI)
Cure AP-4
Department of Health and Human Services (HHS)
German Federal Ministry of Education and Research (BMBF)
Helmholtz Center for Infection Research (HZI)
Manchester Cancer Research Centre (MCRC)
MD Anderson Cancer Center Foundation
National Center for Research and Development (NCRD)
Personalised Medicine (PerMed)
Pharmaceutical Research and Manufacturers Association (PhRMA)
Tigerlily Foundation
University Hospital Erlangen
U.S. Department of Defence (DOD)
University Medical Center Hamburg-Eppendorf (UKE)
University of Bristol (UoB)
University of Sydney
Yale University
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
